vs

Side-by-side financial comparison of HAEMONETICS CORP (HAE) and JBT Marel Corp (JBTM). Click either name above to swap in a different company.

HAEMONETICS CORP is the larger business by last-quarter revenue ($1.3B vs $1.0B, roughly 1.3× JBT Marel Corp). HAEMONETICS CORP runs the higher net margin — 7.3% vs 5.3%, a 2.0% gap on every dollar of revenue. On growth, JBT Marel Corp posted the faster year-over-year revenue change (115.6% vs 4.8%). HAEMONETICS CORP produced more free cash flow last quarter ($209.9M vs $83.5M). Over the past eight quarters, HAEMONETICS CORP's revenue compounded faster (99.2% CAGR vs 60.3%).

Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.

JBT Marel Corporation, formerly known as JBT Corporation, or John Bean Technologies Corporation, is a food processing machinery and automated vehicle company. The company was incorporated in 2008 when FMC Technologies divested its non-energy businesses. The company is based in Chicago, Illinois and traces its history back to a company founded in 1884 by John Bean, an orchardist in Los Gatos, California.

HAE vs JBTM — Head-to-Head

Bigger by revenue
HAE
HAE
1.3× larger
HAE
$1.3B
$1.0B
JBTM
Growing faster (revenue YoY)
JBTM
JBTM
+110.8% gap
JBTM
115.6%
4.8%
HAE
Higher net margin
HAE
HAE
2.0% more per $
HAE
7.3%
5.3%
JBTM
More free cash flow
HAE
HAE
$126.4M more FCF
HAE
$209.9M
$83.5M
JBTM
Faster 2-yr revenue CAGR
HAE
HAE
Annualised
HAE
99.2%
60.3%
JBTM

Income Statement — Q4 FY2026 vs Q4 FY2025

Metric
HAE
HAE
JBTM
JBTM
Revenue
$1.3B
$1.0B
Net Profit
$97.3M
$53.1M
Gross Margin
14.9%
34.5%
Operating Margin
83.4%
7.2%
Net Margin
7.3%
5.3%
Revenue YoY
4.8%
115.6%
Net Profit YoY
-42.0%
858.6%
EPS (diluted)
$1.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HAE
HAE
JBTM
JBTM
Q1 26
$1.3B
Q4 25
$339.0M
$1.0B
Q3 25
$327.3M
$1.0B
Q2 25
$321.4M
$934.8M
Q1 25
$330.6M
$854.1M
Q4 24
$348.5M
$467.6M
Q3 24
$345.5M
$453.8M
Q2 24
$336.2M
$402.3M
Net Profit
HAE
HAE
JBTM
JBTM
Q1 26
$97.3M
Q4 25
$44.7M
$53.1M
Q3 25
$38.7M
$66.0M
Q2 25
$34.0M
$3.4M
Q1 25
$58.0M
$-173.0M
Q4 24
$37.5M
$-7.0M
Q3 24
$33.8M
$38.9M
Q2 24
$38.4M
$30.7M
Gross Margin
HAE
HAE
JBTM
JBTM
Q1 26
14.9%
Q4 25
59.7%
34.5%
Q3 25
59.5%
35.9%
Q2 25
59.8%
35.8%
Q1 25
58.4%
34.2%
Q4 24
55.5%
38.4%
Q3 24
54.2%
36.1%
Q2 24
52.0%
35.6%
Operating Margin
HAE
HAE
JBTM
JBTM
Q1 26
83.4%
Q4 25
19.9%
7.2%
Q3 25
17.9%
10.2%
Q2 25
16.8%
5.2%
Q1 25
21.6%
-3.9%
Q4 24
16.9%
3.4%
Q3 24
15.0%
10.3%
Q2 24
11.8%
6.7%
Net Margin
HAE
HAE
JBTM
JBTM
Q1 26
7.3%
Q4 25
13.2%
5.3%
Q3 25
11.8%
6.6%
Q2 25
10.6%
0.4%
Q1 25
17.5%
-20.3%
Q4 24
10.8%
-1.5%
Q3 24
9.8%
8.6%
Q2 24
11.4%
7.6%
EPS (diluted)
HAE
HAE
JBTM
JBTM
Q1 26
Q4 25
$0.95
$1.04
Q3 25
$0.81
$1.26
Q2 25
$0.70
$0.07
Q1 25
$1.17
$-3.35
Q4 24
$0.74
$-0.22
Q3 24
$0.66
$1.21
Q2 24
$0.74
$0.95

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HAE
HAE
JBTM
JBTM
Cash + ST InvestmentsLiquidity on hand
$245.4M
$167.9M
Total DebtLower is stronger
$1.2B
$1.5B
Stockholders' EquityBook value
$796.3M
$4.5B
Total Assets
$2.4B
$8.2B
Debt / EquityLower = less leverage
1.53×
0.33×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HAE
HAE
JBTM
JBTM
Q1 26
$245.4M
Q4 25
$363.4M
$167.9M
Q3 25
$296.4M
Q2 25
$292.9M
Q1 25
$306.8M
Q4 24
$320.8M
$1.2B
Q3 24
$299.3M
Q2 24
$344.4M
Total Debt
HAE
HAE
JBTM
JBTM
Q1 26
$1.2B
Q4 25
$1.2B
$1.5B
Q3 25
$1.2B
$1.5B
Q2 25
$1.2B
$1.5B
Q1 25
$1.2B
$2.0B
Q4 24
$1.3B
Q3 24
$648.3M
Q2 24
$647.7M
Stockholders' Equity
HAE
HAE
JBTM
JBTM
Q1 26
$796.3M
Q4 25
$911.5M
$4.5B
Q3 25
$849.2M
$4.4B
Q2 25
$882.3M
$4.4B
Q1 25
$820.8M
$4.1B
Q4 24
$906.9M
$1.5B
Q3 24
$878.9M
$1.6B
Q2 24
$905.4M
$1.5B
Total Assets
HAE
HAE
JBTM
JBTM
Q1 26
$2.4B
Q4 25
$2.5B
$8.2B
Q3 25
$2.4B
$8.2B
Q2 25
$2.5B
$8.3B
Q1 25
$2.5B
$8.0B
Q4 24
$2.5B
$3.4B
Q3 24
$2.5B
$2.8B
Q2 24
$2.5B
$2.7B
Debt / Equity
HAE
HAE
JBTM
JBTM
Q1 26
1.53×
Q4 25
1.34×
0.33×
Q3 25
1.44×
0.34×
Q2 25
1.39×
0.35×
Q1 25
1.49×
0.48×
Q4 24
0.81×
Q3 24
0.41×
Q2 24
0.43×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HAE
HAE
JBTM
JBTM
Operating Cash FlowLast quarter
$293.2M
$117.4M
Free Cash FlowOCF − Capex
$209.9M
$83.5M
FCF MarginFCF / Revenue
15.7%
8.3%
Capex IntensityCapex / Revenue
2.5%
3.4%
Cash ConversionOCF / Net Profit
3.01×
2.21×
TTM Free Cash FlowTrailing 4 quarters
$417.1M
$238.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HAE
HAE
JBTM
JBTM
Q1 26
$293.2M
Q4 25
$93.6M
$117.4M
Q3 25
$111.3M
$87.7M
Q2 25
$17.4M
$102.2M
Q1 25
$116.6M
$34.4M
Q4 24
$43.8M
$128.7M
Q3 24
$48.8M
$71.9M
Q2 24
$-27.4M
$21.6M
Free Cash Flow
HAE
HAE
JBTM
JBTM
Q1 26
$209.9M
Q4 25
$87.2M
$83.5M
Q3 25
$106.3M
$56.5M
Q2 25
$13.6M
$83.7M
Q1 25
$100.9M
$14.4M
Q4 24
$35.2M
$118.7M
Q3 24
$39.4M
$65.0M
Q2 24
$-33.1M
$11.1M
FCF Margin
HAE
HAE
JBTM
JBTM
Q1 26
15.7%
Q4 25
25.7%
8.3%
Q3 25
32.5%
5.6%
Q2 25
4.2%
9.0%
Q1 25
30.5%
1.7%
Q4 24
10.1%
25.4%
Q3 24
11.4%
14.3%
Q2 24
-9.8%
2.8%
Capex Intensity
HAE
HAE
JBTM
JBTM
Q1 26
2.5%
Q4 25
1.9%
3.4%
Q3 25
1.5%
3.1%
Q2 25
1.2%
2.0%
Q1 25
4.7%
2.3%
Q4 24
2.5%
2.1%
Q3 24
2.7%
1.5%
Q2 24
1.7%
2.6%
Cash Conversion
HAE
HAE
JBTM
JBTM
Q1 26
3.01×
Q4 25
2.09×
2.21×
Q3 25
2.88×
1.33×
Q2 25
0.51×
30.06×
Q1 25
2.01×
Q4 24
1.17×
Q3 24
1.44×
1.85×
Q2 24
-0.71×
0.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons